These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 18261364

  • 21. Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus.
    Lee JH, Yang SH, Oh JM, Lee MG.
    J Pharm Pharmacol; 2010 Jan; 62(1):1-23. PubMed ID: 20722995
    [Abstract] [Full Text] [Related]

  • 22. Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
    Kang HE, Sohn SI, Baek SR, Lee JW, Lee MG.
    Metabolism; 2010 Oct; 59(10):1472-80. PubMed ID: 20170928
    [Abstract] [Full Text] [Related]

  • 23. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
    Lee DY, Shin HS, Bae SK, Lee MG.
    Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
    [Abstract] [Full Text] [Related]

  • 24. Comparative pharmacokinetic study of paclitaxel and docetaxel in streptozotocin-induced diabetic rats.
    Lee JH, Lee A, Oh JH, Lee YJ.
    Biopharm Drug Dispos; 2012 Nov; 33(8):474-86. PubMed ID: 22936118
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats.
    Lee YS, Choi YH, Kim TK, Ryu KH, Lee BY, Lee MG.
    Xenobiotica; 2010 Feb; 40(2):129-37. PubMed ID: 19929308
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin.
    Kim YC, Kwon JW, Kim WB, Lee I, Lee MG.
    J Pharm Sci; 2004 Sep; 93(9):2374-87. PubMed ID: 15295797
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
    Ramakrishna R, Bhateria M, Singh R, Bhatta RS.
    J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours.
    Lee DY, Shin HS, Lee I, Lee MG.
    Biopharm Drug Dispos; 2006 Nov; 27(8):361-70. PubMed ID: 16894645
    [Abstract] [Full Text] [Related]

  • 30. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
    Hu N, Xie S, Liu L, Wang X, Pan X, Chen G, Zhang L, Liu H, Liu X, Liu X, Xie L, Wang G.
    Drug Metab Dispos; 2011 Mar; 39(3):419-25. PubMed ID: 21135265
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of omeprazole in rats with dextran sulfate sodium-induced ulcerative colitis.
    Hu N, Ling J, Dong L, Jiang Y, Zhou Q, Zou S.
    Drug Metab Pharmacokinet; 2020 Jun; 35(3):297-303. PubMed ID: 32354532
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of 5-fluorouracil in rats with diabetes mellitus induced by streptozotocin.
    Choi YH, Lee AK, Bae SK, Kim SO, Lee MG.
    Biopharm Drug Dispos; 2005 Apr; 26(3):93-8. PubMed ID: 15674819
    [Abstract] [Full Text] [Related]

  • 35. Combined contributions of impaired hepatic CYP2C11 and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes mellitus.
    Liu H, Liu L, Li J, Mei D, Duan R, Hu N, Guo H, Zhong Z, Liu X.
    Drug Metab Dispos; 2012 Jun; 40(6):1104-12. PubMed ID: 22393122
    [Abstract] [Full Text] [Related]

  • 36. Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11.
    Chung HJ, Kang HE, Bae EJ, Lee I, Kim SG, Lee MG.
    J Pharm Sci; 2008 Nov; 97(11):5024-36. PubMed ID: 18314883
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of bacterial lipopolysaccharide on the pharmacokinetics of metformin in rats.
    Choi YH, Lee I, Lee MG.
    Int J Pharm; 2007 Jun 07; 337(1-2):194-201. PubMed ID: 17275228
    [Abstract] [Full Text] [Related]

  • 39. Effects of cytochrome P450 (CYP) inducers and inhibitors on ondansetron pharmacokinetics in rats: involvement of hepatic CYP2D subfamily and 3A1/2 in ondansetron metabolism.
    Yang SH, Lee MG.
    J Pharm Pharmacol; 2008 Jul 07; 60(7):853-61. PubMed ID: 18549671
    [Abstract] [Full Text] [Related]

  • 40. Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat.
    Sakuma T, Honma R, Maguchi S, Tamaki H, Nemoto N.
    Xenobiotica; 2001 Apr 07; 31(4):223-37. PubMed ID: 11465407
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.